220 related articles for article (PubMed ID: 36525200)
1. Comparative study on the topical and transdermal delivery of diclofenac incorporated in nano-emulsions, nano-emulgels, and a colloidal suspension.
Louw EV; Liebenberg W; Willers C; Dube A; Aucamp ME; Gerber M
Drug Deliv Transl Res; 2023 May; 13(5):1372-1389. PubMed ID: 36525200
[TBL] [Abstract][Full Text] [Related]
2. Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems.
Myburgh J; Liebenberg W; Willers C; Dube A; Gerber M
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896173
[TBL] [Abstract][Full Text] [Related]
3. Traversing the Skin Barrier with Nano-emulsions.
Burger C; Shahzad Y; Brummer A; Gerber M; du Plessis J
Curr Drug Deliv; 2017; 14(4):458-472. PubMed ID: 27557672
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of nano-emulsions and nano-emulgels for transdermal delivery of statins.
Sithole MN; Marais S; Maree SM; Du Plessis LH; Du Plessis J; Gerber M
Expert Opin Drug Deliv; 2021 Jun; 18(6):789-801. PubMed ID: 33393386
[TBL] [Abstract][Full Text] [Related]
5. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
Sintov AC; Botner S
Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
[TBL] [Abstract][Full Text] [Related]
6. Cubic liquid crystalline structures in diluted, concentrated and highly concentrated emulsions for topical application: Influence on drug release and human skin permeation.
Arias EM; Guiró P; Rodriguez-Abreu C; Solans C; Escribano-Ferrer E; García-Celma MJ
Int J Pharm; 2019 Oct; 569():118531. PubMed ID: 31323372
[TBL] [Abstract][Full Text] [Related]
7. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance.
Badruddoza AZM; Zahid MI; Walsh T; Shah J; Gates D; Yeoh T; Nurunnabi M
Int J Pharm; 2024 Jun; 658():124210. PubMed ID: 38718972
[TBL] [Abstract][Full Text] [Related]
8. Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate.
Burger C; Aucamp M; du Preez J; Haynes RK; Ngwane A; du Plessis J; Gerber M
Pharm Res; 2018 Aug; 35(10):186. PubMed ID: 30088097
[TBL] [Abstract][Full Text] [Related]
9. Topical vehicles based on natural surfactant/fatty alcohols mixed emulsifier: The influence of two polyols on the colloidal structure and in vitro/in vivo skin performance.
Savic S; Weber C; Tamburic S; Savic M; Müller-Goymann C
J Pharm Sci; 2009 Jun; 98(6):2073-90. PubMed ID: 18937361
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.
Liu D; Ge Y; Tang Y; Yuan Y; Zhang Q; Li R; Xu Q
J Microencapsul; 2010; 27(8):726-34. PubMed ID: 21034365
[TBL] [Abstract][Full Text] [Related]
11. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
Arora P; Mukherjee B
J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
[TBL] [Abstract][Full Text] [Related]
12. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
13. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
14. Whey protein/polysaccharide-stabilized emulsions: Effect of polymer type and pH on release and topical delivery of salicylic acid.
Combrinck J; Otto A; du Plessis J
AAPS PharmSciTech; 2014 Jun; 15(3):588-600. PubMed ID: 24550100
[TBL] [Abstract][Full Text] [Related]
15. Vehicle influence on permeation through intact and compromised skin.
Gujjar M; Banga AK
Int J Pharm; 2014 Sep; 472(1-2):362-8. PubMed ID: 24979534
[TBL] [Abstract][Full Text] [Related]
16. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
Fouad SA; Basalious EB; El-Nabarawi MA; Tayel SA
Int J Pharm; 2013 Sep; 453(2):569-78. PubMed ID: 23792042
[TBL] [Abstract][Full Text] [Related]
17. Cationic polymer-based micro-emulgel with self-preserving ability for transdermal delivery of diclofenac sodium.
Yang C; Shen Y; Wang J; Ouahab A; Zhang T; Tu J
Drug Deliv; 2015; 22(6):814-22. PubMed ID: 24724988
[TBL] [Abstract][Full Text] [Related]
18. Effect of vehicles on diclofenac permeation across excised rat skin.
Takahashi K; Suzuki T; Sakano H; Mizuno N
Biol Pharm Bull; 1995 Apr; 18(4):571-5. PubMed ID: 7655430
[TBL] [Abstract][Full Text] [Related]
19. Optimised transdermal delivery of pravastatin.
Burger C; Gerber M; du Preez JL; du Plessis J
Int J Pharm; 2015 Dec; 496(2):518-25. PubMed ID: 26505148
[TBL] [Abstract][Full Text] [Related]
20. Natural surfactant-based topical vehicles for two model drugs: Influence of different lipophilic excipients on in vitro/in vivo skin performance.
Savić S; Weber C; Savić MM; Müller-Goymann C
Int J Pharm; 2009 Nov; 381(2):220-30. PubMed ID: 19616085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
